Servier announces a strategic worldwide licensing agreement for Black Diamond Therapeutics' BDTX-4933 for solid tumors for an ...
Pharmaceutical Technology on MSN3d
Servier and Black Diamond sign deal for solid tumours therapyServier will be responsible for development and global commercialisation of the therapy for several indications.
Stocktwits on MSN3d
Black Diamond Therapeutics Shares Jump On New Partnership With France-Based Servier: Retail Sentiment Hits Year-HighShares of Black Diamond Therapeutics, Inc. (BDTX) jumped around 21% as of Wednesday noon after the company announced it had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback